Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner |
Dai, Wen-Ling
(Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University)
Liu, Xin-Tong (School of Life Science and Technology, China Pharmaceutical University) Bao, Yi-Ni (Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University) Yan, Bing (Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University) Jiang, Nan (Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University) Yu, Bo-Yang (State Key Laboratory of Natural Medicines, China Pharmaceutical University) Liu, Ji-Hua (Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University) |
1 | Matthes, H. W. et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819-823 (1996). DOI |
2 | Le Merrer, J., Becker, J. A., Befort, K. & Kieffer, B. L. Reward processing by the opioid system in the brain. Physiol. Rev. 89, 1379-1412 (2009). DOI |
3 | Dang, V. C., Chieng, B., Azriel, Y. & Christie, M. J. Cellular morphine tolerance produced by betaarrestin-2-dependent impairment of mu-opioid receptor resensitization. J. Neurosci. 31, 7122-7130 (2011). DOI |
4 | Bohn, L. M. et al. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286, 2495-2498 (1999). DOI |
5 | Raehal, K. M. & Bohn, L. M. The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics. Neuropharmacology 60, 58-65 (2011). DOI |
6 | Klewe, I. V. et al. Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling. Neuropharmacology 54, 1215-1222 (2008). DOI |
7 | Basu, D. et al. Effects of the dopamine D2 allosteric modulator, PAOPA, on the expression of GRK2, arrestin-3, ERK1/2, and on receptor internalization. PLoS One 8, e70736 (2013). DOI |
8 | Wang, J. et al. miR-365 targets beta-arrestin 2 to reverse morphine tolerance in rats. Sci. Rep. 6, 38285 (2016). DOI |
9 | Xu, J. T. et al. Opioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesia. J. Clin. Invest. 124, 592-603 (2014). DOI |
10 | Khan, S. M. et al. The expanding roles of Gbetagamma subunits in G proteincoupled receptor signaling and drug action. Pharmacol. Rev. 65, 545-577 (2013). DOI |
11 | Nair, V. D. & Sealfon, S. C. Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. J. Biol. Chem. 278, 47053-47061 (2003). DOI |
12 | Chen, Y. & Sommer, C. The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence. Mol. Neurobiol. 40, 101-107 (2009). DOI |
13 | Steelman, L. S. et al. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18, 189-218 (2004). DOI |
14 | Narkar, V. A., Hussain, T., Pedemonte, C. & Lokhandwala, M. F. Dopamine D(2) receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. J. Am. Soc. Nephrol. 12, 1844-1852 (2001). |
15 | Advokat, C. Tolerance to the antinociceptive effect of morphine in spinally transected rats. Behav. Neurosci. 103, 1091-1098 (1989). DOI |
16 | Lai, E. C., Hsieh, C. Y., Kao Yang, Y. H. & Lin, S. J. Detecting potential adverse reactions of sulpiride in schizophrenic patients by prescription sequence symmetry analysis. PLoS One 9, e89795 (2014). DOI |
17 | Noori-Daloii, M. R. et al. Use of siRNA in knocking down of dopamine receptors, a possible therapeutic option in neuropsychiatric disorders. Mol. Biol. Rep. 39, 2003-2010 (2012). DOI |
18 | Inturrisi, C. E. Clinical pharmacology of opioids for pain. Clin. J. Pain. 18, S3-S13 (2002). DOI |
19 | Hu, Y. et al. Levo-corydalmine alleviates neuropathic cancer pain induced by tumor compression via the CCL2/CCR2 pathway. Molecules 22, 937 (2017). DOI |
20 | Kreek, M. J. Drug addictions. Molecular and cellular endpoints. Ann. N. Y. Acad. Sci. 937, 27-49 (2001). |
21 | Hutchinson, M. R. et al. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol. Rev. 63, 772-810 (2011). DOI |
22 |
Williams, J. T. et al. Regulation of |
23 | He, S. Q. et al. Facilitation of mu-opioid receptor activity by preventing deltaopioid receptor-mediated codegradation. Neuron 69, 120-131 (2011). DOI |
24 | Nair, V. D., Olanow, C. W. & Sealfon, S. C. Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines. Biochem. J. 373, 25-32 (2003). DOI |
25 | Zhou, L. et al. Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1/CXCR2 signaling pathway. Neuropharmacology 135, 34-47 (2018). DOI |
26 | Trescot, A. M., Datta, S., Lee, M. & Hansen, H. Opioid pharmacology. Pain Physician 11, S133-S153 (2008). |
27 | Yang, C. H. et al. Antinociceptive potentiation and attenuation of tolerance by intrathecal beta-arrestin 2 small interfering RNA in rats. Br. J. Anaesth. 107, 774-781 (2011). DOI |
28 | Beaulieu, J. M. & Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev. 63, 182-217 (2011). DOI |
29 | Tian, Y. et al. Early single aspirin-triggered Lipoxin blocked morphine antinociception tolerance through inhibiting NALP1 inflammasome: involvement of PI3k/Akt signaling pathway. Brain Behav. Immun. 50, 63-77 (2015). DOI |
30 | Melik Parsadaniantz, S., Rivat, C., Rostene, W. & Reaux-Le Goazigo, A. Opioid and chemokine receptor crosstalk: a promising target for pain therapy? Nat. Rev. Neurosci. 16, 69-78 (2015). |
31 | Zhou, D., Chen, M. L., Zhang, Y. Q. & Zhao, Z. Q. Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats. J. Neurosci. 30, 8042-8047 (2010). DOI |
32 | Ji, R. R. Targeting microglial purinergic signaling to improve morphine analgesia. Pain 150, 377-378 (2010). DOI |
33 | Wei, H., Viisanen, H. & Pertovaara, A. Descending modulation of neuropathic hypersensitivity by dopamine D2 receptors in or adjacent to the hypothalamic A11 cell group. Pharmacol. Res. 59, 355-363 (2009). DOI |
34 | Eidson, L. N. & Murphy, A. Z. Persistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat. J. Pain 14, 393-404 (2013). DOI |
35 | Ferrini, F. et al. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl-homeostasis. Nat. Neurosci. 16, 183-192 (2013). DOI |
36 | Von Willebrand, M. et al. Inhibition of phosphatidylinositol 3-kinase blocks T cell antigen receptor/CD3-induced activation of the mitogen-activated kinase Erk2. Eur. J. Biochem. 235, 828-835 (1996). DOI |
37 | Shen, N. et al. A novel role of spinal astrocytic connexin 43: mediating morphine antinociceptive tolerance by activation of NMDA receptors and inhibition of glutamate transporter-1 in rats. CNS Neurosci. Ther. 20, 728-736 (2014). DOI |
38 | Luo, C., Kuner, T. & Kuner, R. Synaptic plasticity in pathological pain. Trends Neurosci. 37, 343-355 (2014). DOI |
39 | Sheng, H. Y., Qu, C. L., Huo, F. Q., Du, J. Q. & Tang, J. S. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism. Exp. Neurol. 215, 128-134 (2009). DOI |
40 | Shamsizadeh, A. et al. Involvement of dopamine receptors within the dorsal hippocampus in suppression of the formalin-induced orofacial pain. Pharmacol. Biochem. Behav. 114-115, 37-42 (2013). DOI |
41 | Verma, A. & Kulkarni, S. Role of D 1/D 2 dopamine and N-methyl-d-aspartate (NMDA) receptors in morphine tolerance and dependence in mice. Eur. Neuropsychopharm. 5, 81-87 (1995). DOI |
42 | Cross, D. A. E. et al. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle Cell Line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem. J. 303, 21-26 (1994). DOI |
43 | Conway, A. M., Rakhit, S., Pyne, S. & Pyne, N. J. Platelet-derived-growth-factor stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle: role of pertussis-toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase. Biochem. J. 337, 171-177 (1999). DOI |
44 | King, M. A., Bradshaw, S., Chang, A. H., Pintar, J. E. & Pasternak, G. W. Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system. J. Neurosci. 21, 7788-7792 (2001). DOI |
45 | Zarrindast, M. R., Dinkoub, Z., Homayoun, H., Bakhtiarian, A. & Khavandgar, S. Dopamine receptor mechanism (s) and morphine tolerance in mice. J. Psychopharmacol. 16, 261-266 (2002). DOI |
46 | Ozdemir, E., Bagcivan, I. & Gursoy, S. Role of D(1)/D(2) dopamin receptors antagonist perphenazine in morphine analgesia and tolerance in rats. Bosn. J. Basic. Med. Sci. 13, 119-125 (2013). DOI |
47 | Xiao, W. et al. Characterization of human metabolism and disposition of levotetrahydropalmatine: qualitative and quantitative determination of oxidative and conjugated metabolites. J. Pharm. Biomed. Anal. 128, 371-381 (2016). DOI |
48 | Ferby, I. M., Waga, I., Hoshino, M., Kume, K. & Shimizu, T. Wortmannin inhibits mitogen-activated protein kinase activation by platelet-activating factor through a mechanism independent of p85/p110-type phosphatidylinositol 3-kinase. J. Biol. Chem. 271, 11684-11688 (1996). DOI |
49 | Dai, W. L. et al. Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord. Sci. Rep. 6, 38746 (2016). DOI |
50 | Dai, W. L. et al. Simultaneous inhibition of NMDA and mGlu1/5 receptors by levo-corydalmine in rat spinal cord attenuates bone cancer pain. Int. J. Cancer 141, 805-815 (2017). DOI |
51 | Parraga, J. et al. 2,3,9- and 2,3,11-trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands. Eur. J. Med. Chem. 68, 150-166 (2013). DOI |
52 | Stone, L. S., MacMillan, L. B., Kitto, K. F., Limbird, L. E. & Wilcox, G. L. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J. Neurosci. 17, 7157-7165 (1997). DOI |
53 | Sun, H. et al. Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile. Bioorg. Med Chem. 21, 856-868 (2013). DOI |
54 | Njoo, C., Heinl, C. & Kuner, R. In vivo SiRNA transfection and gene knockdown in spinal cord via rapid noninvasive lumbar intrathecal injections in mice. J. Vis. Exp. 22, e51229 (2014). |
55 | Gong, N., Fan, H., Ma, A. N., Xiao, Q. & Wang, Y. X. Geniposide and its iridoid analogs exhibit antinociception by acting at the spinal GLP-1 receptors. Neuropharmacology 84, 31-45 (2014). DOI |
56 | Bradman, M. J., Ferrini, F., Salio, C. & Merighi, A. Practical mechanical threshold estimation in rodents using von Frey hairs/Semmes-Weinstein monofilaments: towards a rational method. J. Neurosci. Methods 255, 92-103 (2015). DOI |
57 | Zhang, Y. et al. A novel analgesic isolated from a traditional Chinese medicine. Curr. Biol. 24, 117-123 (2014). DOI |
58 | Wu, X. F. et al. Reopening of ATP-sensitive potassium channels reduces neuropathic pain and regulates astroglial gap junctions in the rat spinal cord. Pain 152, 2605-2615 (2011). DOI |
![]() |